Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 4 30-4, 2004, Pages

  Inoshima, Ichiro ^a   Kuwano, Kazuyoshi ^a   Hamada, Naoki ^a   Yoshimi, Michihiro ^a   Maeyama, Takashige ^a   Hagimoto, Naoki ^a   Nakanishi, Yoichi ^a   Hara, Nobuyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

Author keywords

Idiopathic pulmonary fibrosis

Indexed keywords

BLEOMYCIN; CYCLIN DEPENDENT KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL INTERACTION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENZYME INHIBITION; EPITHELIUM CELL; FIBROBLAST; GENE; GENE INDUCTION; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG FIBROSIS; MOUSE; NONHUMAN; P21 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 1642309698     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00209.2003     Document Type: Article

References (35)

1. Adamson IY, Young L, and Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383, 1988.
2. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165: 277-304, 2002.
3. Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, and Capelozzi VL. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 54: 132-138, 2001.
4. Bardales RH, Xie SS, Schaefer RF, and Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149: 845-852, 1996.
5. Bissonnette N and Hunting DJ. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16: 3461-3469, 1998.
6. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kintzler KW, and Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
7. Guinee D, Jr., Fleming M, Hayashi M, Woodward M, Zhang J, Walls J, Koss M, Ferrans V, and Travis W. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol 149: 531-538, 1996.
8. Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M, Maeyama T, and Hara N. TGF-β1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168: 6470-6478, 2002.
9. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, and Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 16: 91-101, 1997.
10. Harrison JH Jr., Hoyt DG, and Lazo JS. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol Pharmacol 36: 231-238, 1989.
11. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D, and Mushinski JF. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene 9: 3017-3020, 1994.
12. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, and Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
13. Kawashima M, Yatsunami J, Fukuno Y, Nagata M, Tominaga M, and Hayashi S. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung 180: 73-89, 2002.
14. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, and Hara N. Essential roles of the Fas-Fas-ligand pathway in pulmonary fibrosis. J Clin Invest 104: 13-19, 1999.
15. Kuwano K, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, Kaneko Y, Matsuba T, Maeyama T, and Hara N. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 190: 221-229, 2000.
16. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, and Hara N. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154: 477-483, 1996.
17. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, and Hara N. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 280: L316-L325, 2001.
18. Li R, Waga S, Hannon GJ, Beach D, and Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537, 1994.
19. Lu Y, Yamagishi N, Yagi T, and Takebe H. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16: 705-712, 1998.
20. Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, and Hara N. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am J Physiol Lung Cell Mol Physiol 280: L1128-L1137, 2001.
21. Matsuoka H, Arai T, Mori M, Goya S, Kida H, Morishita H, Fujiwara H, Tachibana I, Osaki T, and Hayashi S. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 283: L103-L112, 2002.
22. Mishra A, Doyle NA, and Martin WJ 2nd. Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am J Respir Cell Mol Biol 22: 543-549, 2000.
23. O'Reilly MA, Staversky RJ, Watkins RH, and Maniscalco WM. Accumulation of p21(Cip1/WAF1) during hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 19: 777-785, 1998.
24. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, and Keng PC. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 24: 703-710, 2001.
25. Staversky RJ, Watkins RH, Wright TW, Hernady E, LoMonaco MB, D'Angio CT, Williams JP, Maniscalco WM, and O'Reilly MA. Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am J Pathol 161: 1383-1393, 2000.
26. Suzuki A, Tsutomi Y, Akahane K, Araki T, and Miura M. Resistance to Fas-mediated apoptosis: activation of caspase-3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17: 931-939, 1998.
27. Suzuki A, Tsutomi Y, Miura M, and Akahane K. Caspase-3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18: 1239-1244, 1999.
28. Terzaghi M, Nettesheim P, and Williams ML. Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Res 38: 4546-4553, 1978.
29. Tounekti O, Pron G, Belehradek J Jr, and Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53: 5462-5469, 1993.
30. Tsuburai T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Hasiba T, Ueda A, Ikehara K, Matsuse T, and Ishigatsubo Y. Adenovirus-mediated transfer and overexpression of heme oxygen 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther 13: 1945-1960, 2002.
31. Uhal BD, Joshi I, True AL, Mundle S, Raza A, Pardo A, and Selman M. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 269: L819-L828, 1995.
32. Uhal BD, Wang R, Laukka J, Zhuang J, Soledad-Conrad V, and Filippatos G. Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacol Toxicol 92: 81-87, 2003.
33. Waga S, Hannon GJ, Beach D, and Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.
34. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, and Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 279: L143-L151, 2000.
35. Woessner JFJ. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93: 440-447, 1961.